Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 843, 113-120
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Role of hepcidin in the pathophysiology and diagnosis of anemiaBlood Research, 2013
- Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesisJournal of Clinical Investigation, 2012
- The Hypoxia-Inducible Factor–C/EBPα Axis Controls Ethanol-Mediated Hepcidin RepressionMolecular and Cellular Biology, 2012
- The pleiotropic effects of erythropoietin in infection and inflammationMicrobes and Infection, 2012
- Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulationBlood, 2010
- Iron Homeostasis and the Inflammatory ResponseAnnual Review of Nutrition, 2010
- HIF-2α, but not HIF-1α, promotes iron absorption in miceJournal of Clinical Investigation, 2009
- Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron DeficiencyCell Metabolism, 2009
- Iron regulation and erythropoiesisCurrent Opinion in Hematology, 2008
- Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)Journal of Clinical Investigation, 2007